Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in Scotland.
McGurnaghan SJ, Blackbourn LAK, Caparrotta TM, Mellor J, Barnett A, Collier A, Sattar N, McKnight J, Petrie J, Philip S, Lindsay R, Hughes K, McAllister D, Leese GP, Pearson ER, Wild S, McKeigue PM, Colhoun HM. McGurnaghan SJ, et al. Among authors: caparrotta tm. BMJ Open. 2022 Oct 12;12(10):e063046. doi: 10.1136/bmjopen-2022-063046. BMJ Open. 2022. PMID: 36223968 Free PMC article.
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
Caparrotta TM, Blackbourn LAK, McGurnaghan SJ, Chalmers J, Lindsay R, McCrimmon R, McKnight J, Wild S, Petrie JR, Philip S, McKeigue PM, Webb DJ, Sattar N, Colhoun HM; Scottish Diabetes Research Network–Epidemiology Group. Caparrotta TM, et al. Diabetes Care. 2020 Sep;43(9):2034-2041. doi: 10.2337/dc20-0120. Epub 2020 Jun 24. Diabetes Care. 2020. PMID: 32581068
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O'Reilly JE, Wild SH, Hatam S, Höhn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group. McGurnaghan SJ, et al. Among authors: caparrotta tm. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. doi: 10.1016/S2213-8587(20)30405-8. Epub 2020 Dec 23. Lancet Diabetes Endocrinol. 2021. PMID: 33357491 Free PMC article. Clinical Trial.
Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study.
O'Reilly JE, Jeyam A, Caparrotta TM, Mellor J, Hohn A, McKeigue PM, McGurnaghan SJ, Blackbourn LAK, McCrimmon R, Wild SH, Petrie JR, McKnight JA, Kennon B, Chalmers J, Phillip S, Leese G, Lindsay RS, Sattar N, Gibb FW, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group. O'Reilly JE, et al. Among authors: caparrotta tm. Diabetes Care. 2021 Sep;44(9):2010-2017. doi: 10.2337/dc21-0689. Epub 2021 Jul 8. Diabetes Care. 2021. PMID: 34244330
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
McKeigue PM, Weir A, Bishop J, McGurnaghan SJ, Kennedy S, McAllister D, Robertson C, Wood R, Lone N, Murray J, Caparrotta TM, Smith-Palmer A, Goldberg D, McMenamin J, Ramsay C, Hutchinson S, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group. McKeigue PM, et al. Among authors: caparrotta tm. PLoS Med. 2020 Oct 20;17(10):e1003374. doi: 10.1371/journal.pmed.1003374. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33079969 Free PMC article.
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Höhn A, Jeyam A, Caparrotta TM, McGurnaghan SJ, O'Reilly JE, Blackbourn LAK, McCrimmon RJ, Leese GP, McKnight JA, Kennon B, Lindsay RS, Sattar N, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group. Höhn A, et al. Among authors: caparrotta tm. Diabetologia. 2021 Jun;64(6):1309-1319. doi: 10.1007/s00125-021-05394-7. Epub 2021 Feb 19. Diabetologia. 2021. PMID: 33608768 Free PMC article.
Development and validation of a cardiovascular risk prediction model in type 1 diabetes.
McGurnaghan SJ, McKeigue PM, Read SH, Franzen S, Svensson AM, Colombo M, Livingstone S, Farran B, Caparrotta TM, Blackbourn LAK, Mellor J, Thoma I, Sattar N, Wild SH, Gudbjörnsdottir S, Colhoun HM; Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group. McGurnaghan SJ, et al. Among authors: caparrotta tm. Diabetologia. 2021 Sep;64(9):2001-2011. doi: 10.1007/s00125-021-05478-4. Epub 2021 Jun 9. Diabetologia. 2021. PMID: 34106282 Free PMC article.
23 results